Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule: results from a randomized study (Q35918842)

From Wikidata
Jump to navigation Jump to search
scientific article published in December 2011
edit
Language Label Description Also known as
English
Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule: results from a randomized study
scientific article published in December 2011

    Statements

    Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule: results from a randomized study (English)
    Barbara Romanowski
    Tino F Schwarz
    Linda M Ferguson
    Klaus Peters
    Marc Dionne
    Karin Schulze
    Brian Ramjattan
    Peter Hillemanns
    Grégory Catteau
    Kurt Dobbelaere
    Anne Schuind
    Dominique Descamps
    1 December 2011
    1374-1386

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit